Ndisang Joseph Fomusi
Department of Physiology, College of Medicine, University of Saskatchewan, 107 Wiggins Road, Saskatoon, SK, Canada S7N 5E5.
Curr Pharm Des. 2014;20(9):1318-27. doi: 10.2174/13816128113199990551.
Although recent studies have underscored the role of the heme-oxygenase (HO) inducer hemin, on insulin-signaling and glucose metabolism, the underlying mechanisms are not completely understood. In this study, two-dimensional-gel electrophoresis, massspectrometry and MSACOT-analyses were used to identify and characterize novel proteins modulated by hemin in spontaneoushypertensive rat (SHR), a model of essential hypertension with insulin resistance/impaired glucose metabolism. In addition, the effects of hemin on endothelin-1 (ET-1), protein-tyrosine-phosphatase-1B (PTP-1B), atrial-natriuretic-peptide (ANP) and its surrogate-marker urinary cGMP, and inflammatory cytokines including TNF-α, IL-6 and IL-1β were investigated. In hemin-treated SHR, several proteins related to oxidative-stress and metabolism were modulated. Particularly, hemin enhanced aldolase- B, fumarylacetoacetate hydrolase, purine-nucleoside phosphorylase, adenosine-kinase, argininosuccinate synthetase and carbonic anhydrase-3 all of which are enzymes involved in glucose/energy metabolism and pH homeostasis. Similarly, hemin potentiated antioxidant pathways including, NADP(+)-dependant isocitrate-dehydrogenase, catalase, glutathione-S-transferase-Yb1 and hsp70, a pleiotropic agent that regulates protein-folding, oxidative/pro-inflammatory events. Hemin also increased enzymes implicated in cell-growth such as the nitrilase-protein-family, but reduced betaine-homocysteine methyltransferase, an enzyme associated with insulin resistance and dysfunctional glucose metabolism. Furthermore, hemin increased ANP and its surrogate marker, urinary cGMP, but reduced ET-1, PTP-1B, TNF-α, IL-6, IL-1β, whereas the HO-inhibitor, chromium-mesoporphyrin abolished the effects. The potentiation of ANP, urinary-cGMP, aldolade-B, fumarylacetoacetate hydrolase, purine-nucleoside phosphorylase, adenosine-kinase, argininosuccinate synthetase, carbonic anhydrase-3, hsp70 and the corresponding reduction of betaine-homocysteine methyltransferase, PTP-1B, TNF-α, IL-6, IL-1β, and ET-1 may be responsible for the improved glucose metabolism in hemin-treated animals. Collectively, these findings underscore the pleiotropic effects of the HO-system in cellular homeostasis with important roles in metabolism and defence.
尽管最近的研究强调了血红素加氧酶(HO)诱导剂氯化血红素对胰岛素信号传导和葡萄糖代谢的作用,但其潜在机制尚未完全明确。在本研究中,采用二维凝胶电泳、质谱分析和MSACOT分析,以鉴定和表征氯化血红素在自发性高血压大鼠(SHR)中调节的新蛋白质,SHR是一种伴有胰岛素抵抗/葡萄糖代谢受损的原发性高血压模型。此外,还研究了氯化血红素对内皮素-1(ET-1)、蛋白酪氨酸磷酸酶-1B(PTP-1B)、心钠素(ANP)及其替代标志物尿cGMP,以及包括肿瘤坏死因子-α(TNF-α)、白细胞介素-6(IL-6)和白细胞介素-1β(IL-1β)在内的炎性细胞因子的影响。在接受氯化血红素治疗的SHR中,几种与氧化应激和代谢相关的蛋白质受到调节。特别是,氯化血红素增强了醛缩酶-B、富马酰乙酰乙酸水解酶、嘌呤核苷磷酸化酶、腺苷激酶、精氨酸琥珀酸合成酶和碳酸酐酶-3,所有这些都是参与葡萄糖/能量代谢和pH稳态的酶。同样,氯化血红素增强了抗氧化途径,包括烟酰胺腺嘌呤二核苷酸磷酸(NADP(+))依赖性异柠檬酸脱氢酶、过氧化氢酶、谷胱甘肽-S-转移酶-Yb1和热休克蛋白70(hsp70),热休克蛋白70是一种调节蛋白质折叠、氧化/促炎事件的多效性因子。氯化血红素还增加了与细胞生长相关的酶,如腈水解酶蛋白家族,但降低了甜菜碱-同型半胱氨酸甲基转移酶,该酶与胰岛素抵抗和葡萄糖代谢功能障碍有关。此外,氯化血红素增加了ANP及其替代标志物尿cGMP,但降低了ET-1、PTP-1B、TNF-α、IL-6、IL-1β,而HO抑制剂中卟啉铬消除了这些作用。ANP、尿cGMP、醛缩酶-B、富马酰乙酰乙酸水解酶、嘌呤核苷磷酸化酶、腺苷激酶、精氨酸琥珀酸合成酶、碳酸酐酶-3、hsp70的增强以及相应的甜菜碱-同型半胱氨酸甲基转移酶、PTP-1B、TNF-α、IL-6、IL-1β和ET-1的降低可能是氯化血红素治疗动物中葡萄糖代谢改善的原因。总的来说,这些发现强调了HO系统在细胞内稳态中的多效性作用,在代谢和防御中具有重要作用。